Composition:
Ondansetron 4 mg/ 2 ml, Ondansetron 8 mg/ 4 ml.
Indications:
Adults:
1. For the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.
2. For the prevention and treatment of postoperative nausea and vomiting (PONV).
Packaging:
Ondansetron MIS 4 mg: Ampoule 2 ml, 5 Ampoules/ Box. Solution for Intravenous and Intramuscular injection.
Ondansetron MIS 8 mg: Ampoule 4 ml, 5 Ampoules/ Box. Solution for Intravenous and Intramuscular injection.